European Association for the Study of the Liver. EASL clinical practice guidelines on the management of benign liver tumours. J Hepatol. 2016. https://doi.org/10.1016/j.jhep.2016.04.001.
Casabianca AS, Hernandez Caballero AI, Thornburg LL, Carpizo D. Management of hepatic haemangioma in pregnancy. BMJ Case Rep. 2022. https://doi.org/10.1136/bcr-2022-248932.
Yamamoto T, Kawarada Y, Yano T, Noguchi T, Mizumoto R. Spontaneous rupture of hemangioma of the liver: treatment with transcatheter hepatic arterial embolization. Am J Gastroenterol. 1991;86:1645–9.
Furumaya A, van Rosmalen BV, Takkenberg RB, van Delden OM, Dejong CHC, Verheij J, et al. Transarterial (chemo-)embolization and lipiodolization for hepatic haemangioma. Cardiovasc Interv Radiol. 2019. https://doi.org/10.1007/s00270-019-02169-x.
Torkian P, Li J, Kaufman JA, Jahangiri Y. Effectiveness of transarterial embolization in treatment of symptomatic hepatic hemangiomas: systematic review and meta-analysis. Cardiovasc Interv Radiol. 2021. https://doi.org/10.1007/s00270-020-02611-5.
Caseiro-Alves F, Brito J, Araujo AE, Belo-Soares P, Rodrigues H, Cipriano A, et al. Liver haemangioma: common and uncommon findings and how to improve the differential diagnosis. Eur Radiol. 2007. https://doi.org/10.1007/s00330-006-0503-z.
Akhlaghpoor S, Torkian P, Golzarian J. Transarterial bleomycin-lipiodol embolization (B/LE) for symptomatic giant hepatic hemangioma. Cardiovasc Interv Radiol. 2018. https://doi.org/10.1007/s00270-018-2010-4.
Hasan HY, Hinshaw JL, Borman EJ, Gegios A, Leverson G, Winslow ER. Assessing normal growth of hepatic hemangiomas during long-term follow-up. JAMA Surg. 2014. https://doi.org/10.1001/jamasurg.2014.477.
Bozkaya H, Cinar C, Besir FH, Parıldar M, Oran I. Minimally invasive treatment of giant haemangiomas of the liver: embolisation with bleomycin. Cardiovasc Interv Radiol. 2014. https://doi.org/10.1007/s00270-013-0618-y.
Özden İ, Poyanlı A, Önal Y, Demir AA, Hoş G, Acunaş B. Superselective transarterial chemoembolization as an alternative to surgery in symptomatic/enlarging liver hemangiomas. World J Surg. 2017. https://doi.org/10.1007/s00268-017-4069-5.
Kirnap M, Boyvat F, Boyacioglu S, Hilmioglu F, Moray G, Haberal M. The effect of bleomycin embolization on symptomatic improvement and hemangioma size among patients with giant liver hemangiomas. Open J Gastroenterol. 2018. https://doi.org/10.4236/ojgas.2018.84014.
Geschwind JH. Chemoembolization for hepatocellular carcinoma: Where does the truth lie? J Vasc Interv Radiol. 2002;13(10):991–4. https://doi.org/10.1016/s1051-0443(07)61862-4.
Liang B, Xiong F, Wu H, Wang Y, Dong X, Cheng S, et al. Effect of transcatheter intraarterial therapies on the distribution of doxorubicin in liver cancer in a rabbit model. PLoS ONE. 2013. https://doi.org/10.1371/journal.pone.0076388.
Article PubMed PubMed Central Google Scholar
Season W, Wang W, Chen J, Wang G, Pay L, Wu J. Pingyangmycin iodized oil emulsion plus gelatin sponge particles embolization of hepatic hemangioma study of the efficacy of treatment intervention. Med J Chin Peoples Lib Army. 2015. https://doi.org/10.11855/j.issn.0577-7402.2015.06.19.
Yamashita Y, Ogata I, Urata J, Takahashi M. Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings. Radiology. 1997. https://doi.org/10.1148/radiology.203.1.9122378.
Vilgrain V, Boulos L, Vullierme MP, Denys A, Terris B, Menu Y. Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics. 2000. https://doi.org/10.1148/radiographics.20.2.g00mc01379.
Kim KW, Kim TK, Han JK, Kim AY, Lee HJ, Choi BI. Hepatic hemangiomas with arterioportal shunt: findings at two-phase CT. Radiology. 2001. https://doi.org/10.1148/radiology.219.3.r01ma05707.
Makamure J, Zhao D, Liu Y, Wang Y, Zheng C, Liang B. Hepatic hemangioma with arterioportal shunt: prevalence and lesion characteristics based on DSA, CT and MR imaging. Eur J Radiol. 2019. https://doi.org/10.1016/j.ejrad.2019.108715.
留言 (0)